 Jessica Kendrick
Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 18 | 2025 | 564 | 4.370 |
Why?
| | Kidney Failure, Chronic | 13 | 2023 | 541 | 3.270 |
Why?
| | Renal Dialysis | 10 | 2023 | 423 | 2.770 |
Why?
| | Phosphorus | 6 | 2022 | 93 | 2.130 |
Why?
| | Kidney Diseases | 8 | 2023 | 370 | 1.930 |
Why?
| | Kidney Transplantation | 4 | 2022 | 603 | 1.720 |
Why?
| | Hyperparathyroidism, Secondary | 4 | 2025 | 12 | 1.680 |
Why?
| | Cardiovascular Diseases | 12 | 2023 | 2001 | 1.520 |
Why?
| | Nephrology | 2 | 2024 | 60 | 1.510 |
Why?
| | Bicarbonates | 3 | 2023 | 42 | 1.420 |
Why?
| | Kidney | 11 | 2024 | 1310 | 1.380 |
Why?
| | Ferric Compounds | 2 | 2022 | 46 | 1.370 |
Why?
| | Sucrose | 2 | 2022 | 99 | 1.370 |
Why?
| | Diet | 4 | 2023 | 1204 | 1.280 |
Why?
| | Acidosis | 2 | 2021 | 88 | 1.260 |
Why?
| | Pregnancy Complications | 3 | 2018 | 491 | 1.150 |
Why?
| | Vitamin D | 11 | 2018 | 380 | 1.100 |
Why?
| | Glomerular Filtration Rate | 9 | 2024 | 684 | 1.060 |
Why?
| | Blood Pressure | 5 | 2016 | 1712 | 0.980 |
Why?
| | Acute Kidney Injury | 3 | 2023 | 779 | 0.980 |
Why?
| | Potassium | 2 | 2014 | 139 | 0.880 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2024 | 122 | 0.850 |
Why?
| | Fellowships and Scholarships | 2 | 2024 | 272 | 0.840 |
Why?
| | Glomerulonephritis, IGA | 1 | 2023 | 10 | 0.840 |
Why?
| | Hyperphosphatemia | 2 | 2022 | 15 | 0.820 |
Why?
| | Abortion, Legal | 1 | 2023 | 17 | 0.810 |
Why?
| | Sodium Bicarbonate | 2 | 2023 | 37 | 0.810 |
Why?
| | Healthcare Disparities | 3 | 2022 | 579 | 0.800 |
Why?
| | Vitamin D Deficiency | 5 | 2013 | 176 | 0.790 |
Why?
| | Complement Factor B | 1 | 2023 | 105 | 0.780 |
Why?
| | Calcimimetic Agents | 1 | 2021 | 3 | 0.770 |
Why?
| | Transition to Adult Care | 1 | 2023 | 78 | 0.760 |
Why?
| | Hypertension | 4 | 2016 | 1236 | 0.730 |
Why?
| | Peritoneal Dialysis | 1 | 2022 | 95 | 0.710 |
Why?
| | Eating | 1 | 2023 | 369 | 0.700 |
Why?
| | Infant Mortality | 2 | 2018 | 104 | 0.690 |
Why?
| | Humans | 60 | 2025 | 128499 | 0.690 |
Why?
| | Infant, Low Birth Weight | 2 | 2018 | 135 | 0.690 |
Why?
| | Nutritional Status | 3 | 2022 | 326 | 0.660 |
Why?
| | Phosphates | 3 | 2022 | 169 | 0.660 |
Why?
| | Cognition | 2 | 2024 | 1110 | 0.640 |
Why?
| | Pregnancy Outcome | 3 | 2018 | 390 | 0.630 |
Why?
| | Pre-Eclampsia | 2 | 2018 | 185 | 0.620 |
Why?
| | Nutrition Surveys | 5 | 2014 | 261 | 0.610 |
Why?
| | Vascular Calcification | 3 | 2018 | 107 | 0.600 |
Why?
| | Bone Diseases, Metabolic | 1 | 2018 | 59 | 0.570 |
Why?
| | Calcium | 3 | 2021 | 1183 | 0.560 |
Why?
| | Antihypertensive Agents | 3 | 2016 | 482 | 0.550 |
Why?
| | Renal Insufficiency | 1 | 2019 | 148 | 0.540 |
Why?
| | Aged | 22 | 2023 | 21976 | 0.530 |
Why?
| | Living Donors | 1 | 2018 | 287 | 0.520 |
Why?
| | Minerals | 2 | 2015 | 41 | 0.510 |
Why?
| | United States | 13 | 2025 | 13840 | 0.500 |
Why?
| | Middle Aged | 25 | 2023 | 30923 | 0.500 |
Why?
| | Female | 34 | 2024 | 68268 | 0.500 |
Why?
| | Parathyroid Hormone | 6 | 2021 | 106 | 0.480 |
Why?
| | Male | 32 | 2024 | 63045 | 0.480 |
Why?
| | Adult | 20 | 2024 | 35302 | 0.470 |
Why?
| | Prospective Studies | 8 | 2023 | 7069 | 0.470 |
Why?
| | Fibroblast Growth Factors | 4 | 2012 | 170 | 0.470 |
Why?
| | Endothelium, Vascular | 2 | 2018 | 844 | 0.460 |
Why?
| | Risk Factors | 12 | 2020 | 9737 | 0.460 |
Why?
| | Sodium Chloride, Dietary | 1 | 2014 | 28 | 0.450 |
Why?
| | Diabetic Nephropathies | 3 | 2022 | 279 | 0.440 |
Why?
| | Sodium | 1 | 2014 | 202 | 0.430 |
Why?
| | Potassium, Dietary | 1 | 2013 | 11 | 0.420 |
Why?
| | Atherosclerosis | 2 | 2016 | 403 | 0.420 |
Why?
| | Heart Arrest | 1 | 2016 | 307 | 0.410 |
Why?
| | Sodium, Dietary | 1 | 2013 | 37 | 0.410 |
Why?
| | Kidney Function Tests | 2 | 2010 | 145 | 0.400 |
Why?
| | Perception | 1 | 2015 | 336 | 0.390 |
Why?
| | Disease Management | 1 | 2015 | 584 | 0.370 |
Why?
| | Myocardial Infarction | 2 | 2016 | 1015 | 0.360 |
Why?
| | Clinical Trials as Topic | 2 | 2022 | 1003 | 0.360 |
Why?
| | Double-Blind Method | 6 | 2023 | 1856 | 0.350 |
Why?
| | Internship and Residency | 1 | 2020 | 1045 | 0.350 |
Why?
| | Pregnancy | 5 | 2024 | 6373 | 0.350 |
Why?
| | Patient Selection | 1 | 2014 | 661 | 0.350 |
Why?
| | Health Services Accessibility | 1 | 2017 | 901 | 0.350 |
Why?
| | Ankle Brachial Index | 1 | 2010 | 36 | 0.340 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1212 | 0.340 |
Why?
| | Follow-Up Studies | 6 | 2018 | 4874 | 0.340 |
Why?
| | Stroke | 2 | 2016 | 1073 | 0.340 |
Why?
| | Lovastatin | 1 | 2009 | 26 | 0.330 |
Why?
| | Drug Combinations | 2 | 2022 | 324 | 0.320 |
Why?
| | Patient Education as Topic | 1 | 2014 | 734 | 0.320 |
Why?
| | Health Status | 1 | 2014 | 747 | 0.310 |
Why?
| | Renal Artery Obstruction | 1 | 2008 | 29 | 0.300 |
Why?
| | Cohort Studies | 6 | 2019 | 5402 | 0.300 |
Why?
| | Primary Prevention | 1 | 2009 | 188 | 0.290 |
Why?
| | Colitis, Ischemic | 1 | 2007 | 6 | 0.280 |
Why?
| | Proportional Hazards Models | 3 | 2016 | 1200 | 0.280 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2007 | 28 | 0.280 |
Why?
| | Escherichia coli O157 | 1 | 2007 | 31 | 0.280 |
Why?
| | Attitude of Health Personnel | 1 | 2015 | 1090 | 0.270 |
Why?
| | Incidence | 4 | 2018 | 2638 | 0.270 |
Why?
| | Hemoglobins | 1 | 2009 | 337 | 0.270 |
Why?
| | Escherichia coli Infections | 1 | 2007 | 112 | 0.260 |
Why?
| | Health Surveys | 1 | 2008 | 493 | 0.260 |
Why?
| | Comorbidity | 3 | 2020 | 1541 | 0.260 |
Why?
| | Critical Illness | 2 | 2023 | 755 | 0.260 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2015 | 1276 | 0.260 |
Why?
| | Surveys and Questionnaires | 4 | 2025 | 5371 | 0.260 |
Why?
| | Insulin Resistance | 3 | 2024 | 1164 | 0.250 |
Why?
| | Pilot Projects | 2 | 2022 | 1568 | 0.240 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2024 | 2433 | 0.230 |
Why?
| | Primary Health Care | 1 | 2015 | 1641 | 0.230 |
Why?
| | Pulse Wave Analysis | 2 | 2023 | 246 | 0.220 |
Why?
| | Treatment Outcome | 7 | 2019 | 10162 | 0.220 |
Why?
| | Heart Failure | 1 | 2016 | 2145 | 0.210 |
Why?
| | Coronary Artery Disease | 1 | 2009 | 676 | 0.210 |
Why?
| | Plant Proteins | 1 | 2023 | 88 | 0.210 |
Why?
| | Hyperoxia | 1 | 2024 | 87 | 0.210 |
Why?
| | Albuminuria | 3 | 2020 | 181 | 0.210 |
Why?
| | Military Personnel | 1 | 2009 | 514 | 0.210 |
Why?
| | Communication | 2 | 2022 | 841 | 0.210 |
Why?
| | Proteinuria | 1 | 2023 | 88 | 0.210 |
Why?
| | Kidney Glomerulus | 1 | 2023 | 107 | 0.200 |
Why?
| | Hypoalbuminemia | 1 | 2022 | 30 | 0.200 |
Why?
| | Meals | 1 | 2023 | 118 | 0.190 |
Why?
| | Serum Albumin | 1 | 2022 | 146 | 0.190 |
Why?
| | Disease Progression | 4 | 2015 | 2604 | 0.180 |
Why?
| | Prevalence | 4 | 2017 | 2553 | 0.180 |
Why?
| | Infant, Newborn | 3 | 2018 | 5740 | 0.180 |
Why?
| | Inflammation | 2 | 2009 | 2666 | 0.180 |
Why?
| | Calcinosis | 2 | 2014 | 230 | 0.170 |
Why?
| | Fruit | 1 | 2021 | 131 | 0.170 |
Why?
| | Young Adult | 5 | 2024 | 12349 | 0.170 |
Why?
| | Time Factors | 3 | 2019 | 6506 | 0.170 |
Why?
| | Education, Medical, Graduate | 1 | 2024 | 435 | 0.170 |
Why?
| | Educational Status | 1 | 2022 | 470 | 0.170 |
Why?
| | Complement System Proteins | 1 | 2022 | 308 | 0.160 |
Why?
| | Neuropsychological Tests | 1 | 2024 | 1005 | 0.160 |
Why?
| | Aged, 80 and over | 5 | 2017 | 7057 | 0.160 |
Why?
| | Cognitive Dysfunction | 1 | 2024 | 343 | 0.160 |
Why?
| | Creatinine | 2 | 2020 | 480 | 0.150 |
Why?
| | Chelating Agents | 1 | 2019 | 66 | 0.150 |
Why?
| | Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2018 | 13 | 0.150 |
Why?
| | Receptors, Calcium-Sensing | 1 | 2018 | 6 | 0.150 |
Why?
| | Vitamin D-Binding Protein | 1 | 2018 | 15 | 0.150 |
Why?
| | Career Choice | 1 | 2020 | 207 | 0.150 |
Why?
| | Biomarkers | 3 | 2023 | 3893 | 0.150 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2018 | 90 | 0.150 |
Why?
| | Intestinal Absorption | 1 | 2018 | 99 | 0.150 |
Why?
| | Focus Groups | 1 | 2020 | 452 | 0.140 |
Why?
| | Retrospective Studies | 5 | 2021 | 14472 | 0.140 |
Why?
| | Uric Acid | 1 | 2018 | 160 | 0.140 |
Why?
| | Case-Control Studies | 4 | 2018 | 3339 | 0.140 |
Why?
| | Metformin | 1 | 2020 | 314 | 0.140 |
Why?
| | Adolescent | 6 | 2024 | 20304 | 0.130 |
Why?
| | Diuretics | 1 | 2016 | 75 | 0.130 |
Why?
| | Congenital Abnormalities | 1 | 2017 | 73 | 0.130 |
Why?
| | Odds Ratio | 3 | 2014 | 1019 | 0.130 |
Why?
| | Peptides | 1 | 2021 | 915 | 0.130 |
Why?
| | Cross-Over Studies | 1 | 2018 | 509 | 0.130 |
Why?
| | Prognosis | 2 | 2018 | 3780 | 0.130 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1262 | 0.130 |
Why?
| | Physician-Patient Relations | 1 | 2020 | 530 | 0.120 |
Why?
| | Waiting Lists | 1 | 2017 | 237 | 0.120 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2015 | 89 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2018 | 639 | 0.120 |
Why?
| | Obstetric Labor, Premature | 1 | 2015 | 35 | 0.120 |
Why?
| | Maternal Mortality | 1 | 2015 | 41 | 0.120 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 198 | 0.110 |
Why?
| | Precision Medicine | 1 | 2018 | 386 | 0.110 |
Why?
| | Transcription Factor CHOP | 1 | 2014 | 30 | 0.110 |
Why?
| | Infant, Small for Gestational Age | 1 | 2015 | 84 | 0.110 |
Why?
| | Ethics Committees, Research | 1 | 2014 | 41 | 0.110 |
Why?
| | Cultural Competency | 1 | 2015 | 81 | 0.110 |
Why?
| | Awareness | 1 | 2015 | 99 | 0.110 |
Why?
| | Risk Assessment | 2 | 2017 | 3232 | 0.110 |
Why?
| | Medication Adherence | 1 | 2019 | 558 | 0.110 |
Why?
| | Professional-Patient Relations | 1 | 2015 | 139 | 0.110 |
Why?
| | Premature Birth | 1 | 2017 | 310 | 0.110 |
Why?
| | Cesarean Section | 1 | 2015 | 182 | 0.100 |
Why?
| | Pneumonia, Bacterial | 1 | 2014 | 112 | 0.100 |
Why?
| | Infant | 2 | 2018 | 9001 | 0.100 |
Why?
| | Simvastatin | 2 | 2014 | 55 | 0.100 |
Why?
| | Health Care Surveys | 1 | 2015 | 558 | 0.100 |
Why?
| | Cause of Death | 1 | 2015 | 392 | 0.100 |
Why?
| | Global Health | 1 | 2015 | 330 | 0.100 |
Why?
| | Community-Acquired Infections | 1 | 2014 | 160 | 0.100 |
Why?
| | Logistic Models | 3 | 2014 | 1980 | 0.100 |
Why?
| | Academic Medical Centers | 1 | 2015 | 480 | 0.100 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2015 | 223 | 0.100 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 260 | 0.090 |
Why?
| | Cross-Sectional Studies | 3 | 2013 | 5045 | 0.090 |
Why?
| | Vascular Diseases | 1 | 2014 | 232 | 0.090 |
Why?
| | Cooperative Behavior | 1 | 2014 | 424 | 0.090 |
Why?
| | Chronic Disease | 4 | 2012 | 1692 | 0.090 |
Why?
| | Research | 1 | 2014 | 409 | 0.090 |
Why?
| | Survival Rate | 1 | 2015 | 1871 | 0.090 |
Why?
| | Metabolic Diseases | 1 | 2012 | 104 | 0.090 |
Why?
| | Infant, Premature | 1 | 2015 | 538 | 0.090 |
Why?
| | Fatty Liver | 1 | 2013 | 231 | 0.090 |
Why?
| | Tunica Media | 1 | 2010 | 37 | 0.080 |
Why?
| | Tunica Intima | 1 | 2010 | 80 | 0.080 |
Why?
| | Systole | 1 | 2010 | 190 | 0.080 |
Why?
| | Length of Stay | 1 | 2015 | 1119 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 338 | 0.080 |
Why?
| | Bone and Bones | 1 | 2012 | 298 | 0.080 |
Why?
| | Texas | 1 | 2009 | 227 | 0.080 |
Why?
| | Complement Activation | 2 | 2022 | 367 | 0.080 |
Why?
| | Radioisotope Renography | 1 | 2008 | 4 | 0.080 |
Why?
| | Calcium, Dietary | 1 | 2009 | 56 | 0.080 |
Why?
| | Tomography, Spiral Computed | 1 | 2008 | 27 | 0.080 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2008 | 37 | 0.080 |
Why?
| | Child | 3 | 2023 | 20805 | 0.080 |
Why?
| | Cholecalciferol | 1 | 2009 | 56 | 0.080 |
Why?
| | Cardiovascular System | 1 | 2010 | 137 | 0.070 |
Why?
| | Causality | 1 | 2008 | 116 | 0.070 |
Why?
| | Sepsis | 1 | 2014 | 569 | 0.070 |
Why?
| | Age Distribution | 1 | 2008 | 373 | 0.070 |
Why?
| | Sex Distribution | 1 | 2008 | 358 | 0.070 |
Why?
| | Vitamins | 1 | 2009 | 174 | 0.070 |
Why?
| | Homeostasis | 1 | 2011 | 606 | 0.070 |
Why?
| | Anemia | 1 | 2008 | 160 | 0.070 |
Why?
| | Biopsy, Needle | 1 | 2007 | 187 | 0.070 |
Why?
| | Anastomosis, Surgical | 1 | 2007 | 149 | 0.070 |
Why?
| | Oxidative Stress | 2 | 2014 | 1191 | 0.070 |
Why?
| | Colectomy | 1 | 2007 | 94 | 0.070 |
Why?
| | Magnetic Resonance Angiography | 1 | 2008 | 235 | 0.070 |
Why?
| | Rare Diseases | 1 | 2007 | 100 | 0.070 |
Why?
| | C-Reactive Protein | 1 | 2009 | 398 | 0.070 |
Why?
| | Coronary Disease | 1 | 2008 | 384 | 0.060 |
Why?
| | Abdominal Pain | 1 | 2007 | 144 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2011 | 1358 | 0.060 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 411 | 0.060 |
Why?
| | Ischemia | 1 | 2008 | 394 | 0.060 |
Why?
| | Survival Analysis | 1 | 2008 | 1265 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 1951 | 0.060 |
Why?
| | Colonoscopy | 1 | 2007 | 235 | 0.060 |
Why?
| | Colorado | 1 | 2015 | 4399 | 0.060 |
Why?
| | Dietary Supplements | 1 | 2009 | 531 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2710 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2020 | 3626 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 222 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1668 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2009 | 2719 | 0.050 |
Why?
| | Atypical Hemolytic Uremic Syndrome | 1 | 2022 | 19 | 0.050 |
Why?
| | Intestinal Mucosa | 1 | 2007 | 581 | 0.050 |
Why?
| | Drug Therapy, Combination | 2 | 2015 | 1016 | 0.050 |
Why?
| | Consensus | 1 | 2025 | 610 | 0.050 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2022 | 91 | 0.050 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2022 | 112 | 0.040 |
Why?
| | Oxygen | 1 | 2024 | 901 | 0.040 |
Why?
| | Allopurinol | 1 | 2018 | 60 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2021 | 735 | 0.030 |
Why?
| | Ketocholesterols | 1 | 2014 | 7 | 0.030 |
Why?
| | Ezetimibe | 1 | 2014 | 25 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2014 | 60 | 0.030 |
Why?
| | Azetidines | 1 | 2014 | 40 | 0.030 |
Why?
| | Phenotype | 1 | 2022 | 3051 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2014 | 77 | 0.030 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2014 | 100 | 0.030 |
Why?
| | Insulin | 1 | 2024 | 2316 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2022 | 1217 | 0.030 |
Why?
| | Brachial Artery | 1 | 2014 | 185 | 0.030 |
Why?
| | Aorta | 1 | 2014 | 408 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2012 | 512 | 0.020 |
Why?
| | Lipids | 1 | 2014 | 621 | 0.020 |
Why?
| | Risk | 1 | 2012 | 853 | 0.020 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2013 | 258 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 816 | 0.020 |
Why?
| | Ultrasonography | 1 | 2013 | 712 | 0.020 |
Why?
| | Scandinavian and Nordic Countries | 1 | 2008 | 12 | 0.020 |
Why?
| | Placebos | 1 | 2008 | 201 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1499 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2014 | 2765 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2011 | 803 | 0.010 |
Why?
| | Body Mass Index | 1 | 2013 | 2263 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 5281 | 0.010 |
Why?
| | Animals | 1 | 2014 | 34647 | 0.010 |
Why?
|
|
Kendrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|